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ABSTRACT 
Title of Document: PREVALENCE OF DYSPHAGIA AND COGNITIVE 
IMPAIRMENTS IN ADULTS WITH HIV/AIDS IN THE 
ACUTE CARE SETTING: AN EPIDEMIOLOGICAL STUDY 
 
 Theresa S. Walker, Master of Arts, 2011 
Directed by:  Dr. Barbara Sonies, Department of Hearing and Speech Sciences 
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency 
Syndrome (AIDS) are life-threatening conditions. This virus causes the suppression 
of the immune system, allowing opportunistic infections and diseases to attack the 
body.  Due to these opportunistic infections, individuals with HIV/AIDS are 
susceptible to conditions such as dysphagia (difficulty swallowing), odynophagia 
(painful swallowing), and cognitive impairment (e.g., HIV dementia). The co-
morbidity of these conditions is not clearly documented in the literature. Therefor , in 
this study, the prevalence of dysphagia (with and without cognitive impairment) in 
the HIV/AIDS population was determined by a review of 300 medical charts from 
patients admitted to a metropolitan hospital. Possible associations between the 
conditions and several demographic variables (e.g., age, CD4 cell count, 
recommended diet) were also explored.  Twenty-one percent of the charts of patients 
with HIV/AIDS reported confirmed dysphagia and/or complaints of odynophagia. Of 
that 21%, only about five percent also had a documented cognitive impairment. This 
study supports previous prevalence estimates of dysphagia and odynophagia and 
reports prevalence of concurrent dysphagia and cognitive impairment, a potentially 
challenging complex. Lower CD4 counts were associated with the presence of 
dysphagia in this population. Individuals with dysphagia and cognitive impairments 
were more likely to be older and were more likely to be recommended a restrictive 
diet consistency. Implications and recommendations for future study of this 
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Prevalence of Dysphagia and Cognitive Impairments in Adults with HIV/AIDS in the 
Acute Care Setting: An Epidemiological Study 
Nutritional intake is fundamental to life. If a person is unable to transfer food 
from the mouth to the stomach, they most likely have a disorder known as dysphagia. 
Individuals with dysphagia may be unable to meet their dietary needs without clinical 
intervention. They may also be at risk of developing life-threatening conditions such 
as aspiration pneumonia and malnutrition. 
Human Immunodeficiency Virus (HIV) is a virus that infects an individual’s 
lymphoid system and causes deficiencies in their immune system. Therefore, the 
individual with HIV often has difficulty fighting off infections and life-threat ning 
diseases. Some of the diseases and infections that this population is susceptible to can 
cause dysphagia and thus affect general nutrition and overall health.  
Although many people can develop dysphagia, there are many unanswered 
questions regarding how HIV and Acquired Immunodeficiency Syndrome (AIDS, 
which is the end stage of HIV), affect the ability to swallow. For example, are 
HIV/AIDS patients  especially at risk of developing dysphagia because of th ir 
compromised immune system? How often do individuals with HIV/AIDS develop 
dysphagia? What are the underlying causes of their dysphagia?   How do specialists 
such as speech-language pathologists, who are closely involved in dysphagia care, 
treat this population?  
With the exception of a few studies, the literature in this topic area is not clear 
in regards to the incidence/prevalence of dysphagia, the severity of dysphagia, or the 
role of the speech pathologist in the care of these patients. In order to better explore
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and understand this topic, this study examines these factors as they relate to 
individuals with HIV/AIDS. It examines these questions by reviewing the medical 
charts of a population of patients at a large urban hospital with a significant 
HIV/AIDS patient population. This large population pool is unique because previous 
studies have only had small population sizes.  
HIV/AIDS: Background 
As of 2009, there have been an estimated 1.7 million people in the United 
States infected and living with the Human Immunodeficiency Virus (HIV) and over 
468,000 living with Acquired Immunodeficiency Syndrome (AIDS) (Kaiser Family 
Foundation, 2009). HIV is a chronic, progressive viral infection that is transmitted 
through blood and blood products, seminal/vaginal fluid, and breast milk (Fitzgerald 
et al., 2010). HIV is a ribonucleic acid (RNA) virus that uses reverse transcripta e to 
convert viral DNA and infiltrate the host cell genome (Bell, 2004). HIV targets 
lymphocytes primarily by means of host cell surface CD4+ (cluster differentiation 4) 
and chemokine receptors (Bell, 2004). Acquired immunodeficiency syndrome (AIDS) 
is the terminal phase of HIV infection. The virus systemically weakens the body due 
to the destruction of the immune system.  
This infection occurs in several phases. The first phase is the initial HIV 
infection, typically through blood or vaginal/seminal fluid transfer during sexual 
activity or intravenous drug use. The virus infects the CD4+ T cells and rapidly 
replicates, spreading to various organs such as the spleen and lymph nodes. This is 
evidenced through a high viral load and a low CD4+ cell count. Clinically, newly 
infected individuals may experience a brief period of flu-like symptoms or have no 
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symptoms at all. After this acute infection, the virus can lie dormant in the body for a 
period of time. Then, after two to four weeks, the immune system uses killer T cells, 
known as CD8+ T cells, and antibodies to fight against the virus, which results in 
reduced viral loads, and higher CD4+ cell counts. Next, the virus may go into a 
latency period in which HIV-related complications are absent, yet the virus continues 
to replicate in the lymphoid organs. Also during this time, depending on the 
individual, the virus may be active and the CD4 count can fall and/or the viral load 
level can increase. This leaves the individual susceptible to opportunistic infections or 
diseases. Therefore, medical intervention through HIV medication may be 
recommended. Finally, after an indeterminate amount of time, the infection can 
progress to AIDS. This occurs when the individual is immunocompromised to the 
point in which they can no longer fight off infection independently. The viral load 
once again increases and the CD4+ cell decreases (National Institutes of Health,
2009).  The body is again susceptible to opportunistic infections that can cause more 
health complications.  
Clinically, AIDS is defined as having at least 1 opportunistic infection and a 
critically low CD4+ cell count (Castro et al., 1992). The time between the initial HIV 
infection to the progression to AIDS varies per individual, ranging from five to 
twenty years (Uyl, van der Horst-Bruinsma & van Agtmael, 2004).  
Medical professionals who work with HIV/AIDS patients use several tests to 
diagnose an HIV infection. One of the ways to diagnose and monitor the progression 
of the infection is through the cluster differentiation count (CD4), which is collected 
by a blood draw and analysis. This count indicates the health of the immune system 
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because CD4+ (which is found on the surface of helper T-lymphocytes) is a major 
receptor of the HIV virus (Fitzgerald et al., 2010). Physicians and researchers use this 
value to stage the progression of the virus and to determine when medicinal 
intervention is warranted. A healthy adult’s CD4 count is between 500-1500 cells per 
micro liter. Individuals with HIV, especially in the asymptomatic stage or th se who 
are under constant medical supervision with a medicinal regimen, can maintain a 
CD4 count in this range. It has been found that even if the CD4 count is greater than 
500, individuals with HIV can have complications such as Acute Retroviral 
syndrome, candidial vaginitis, Guillian-Barre disease, or aseptic meningitis (Bartlett, 
Gallant, & Pham, 2010). Individuals with a CD4 count of 200-500 are still classified 
as having HIV, but they are more at risk of contracting opportunistic infections. In 
this range, it is normally recommended that the individual begin a medicinal regimen 
to help raise the CD4 count and decrease the viral load. Once the virus reduces the 
CD4+ T lymphocyte count below 200 cells/µl3, the disease may now be classified as 
AIDS, and the individual is at the most risk of developing complications due to 
opportunistic infection (Castro et al., 1992). In summary, the Centers for Disease 
Control (Castro, et al., 1992) define the three CD4+ T-lymphocyte categories as 
follows:  
• Category 1: greater than or equal to 500 cells/µl3 
• Category 2: 200-499 cells/µ3  
• Category 3: less than 200 cells/µl3 
The HIV/AIDS population is continually surviving longer due to improved 
management of associated opportunistic diseases and due to the development of 
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highly active antiretroviral therapy (HAART), which incorporates drugs to block 
aspects of viral replication (transcriptase and protease) (Bell, 2004). HAART has the 
capability to improve immune function, decrease symptoms that manifest in the 
central nervous system (CNS) and prevent opportunistic diseases and infections (Bell, 
2004). 
 Nonetheless, HIV/AIDS has the potential to cause devastating and debilitating 
diseases because the body’s immune system is decimated. Common diseases and 
opportunistic infections include various cancers (e.g. Kaposi’s sarcoma, lymphoma), 
pulmonary diseases (e.g. tuberculosis, pneumonia), gastrointestinal diseases (e.g. 
esophagitis, candidiasis), and neurological diseases and events (e.g. toxoplasmosis, 
progressive multifocal leukoencephalopathy (PML), cerebrovascular accident (CVA), 
etc.) (Castro et al., 1992). These diseases affect the individual’s abilityto carry out 
activities of daily living (ALDs) and each opportunistic disease has the potential to 
cause death if left untreated.  
 These diseases and infections often create a ‘ripple effect’ of disorders and 
symptoms for an individual with HIV/AIDS, meaning that one opportunistic disease 
can cause complications that include other disorders. For example, an individual who 
suffers a stroke or CVA because of the HIV infection may now have nerve damage, 
which could result in dysphagia, cognitive deficits, or several other neurological 
disorders. The effects of the initial opportunistic condition thus ‘ripple’ out to create 
other disorders.  This study explores how frequently the ‘rippled’ disorders of 
dysphagia (impaired swallowing), odynophagia (painful swallowing) and cognitive 
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deficits (e.g., dementia, cognitive-motor disorders) affect individuals with HIV and 
AIDS.  
HIV/AIDS and Dysphagia 
Dysphagia is a disorder in passing food from the mouth to the stomach in 
which an individual may have difficulty swallowing and chewing. Dysphagia is not 
only a motor impairment but can include sensory, cognitive, and emotional 
difficulties that affect chewing and swallowing. In general, dysphagia can be caused 
by changes in the musculature, structure, or neurological (nerve) functions of the oral, 
pharyngeal, laryngeal, and esophageal structures and cavities. Inflammation of those 
oropharyngeal or esophageal structures occurs frequently in individuals with HIV, 
thereby causing dysphagia. Associated feeding and swallowing symptoms such as 
xerostomia (extreme dry mouth), aspiration (solid or liquid material entering the 
airway), and odynophagia also arise in individuals with HIV/AIDS. Dysphagia and 
odynophagia are often major complaints reported by individuals with HIV/AIDS 
(Bahl & Hickson, 1995).  
Swallowing difficulties in this population are most often associated with the 
opportunistic infections of HIV/AIDS (Goldberg, 1993). HIV-related lymphomas or 
malignancies (e.g., Non-Hodgkin’s lymphoma and Kaposi’s sarcoma) may cause
structural changes in the oral, pharyngeal, and esophageal cavities. The following 
inflammations and infections can also be the cause of structural changes: oral or 
esophageal candidiasis, oral thrush, herpes simplex virus (HSV), and cytomegal virus 
(CMV). Candidiasis is the most frequent finding (Ranganathan & Hemalatha, 2006).
Notably, candidiasis can be observed at the beginning of HIV infection, as a sign of 
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immunosuppression (Barr, 1992), and is seen in 90% of AIDS patients (Sanjar, 
Queiroz, Miziara, 2011; Vazquez, 2000). A meta-analysis of HIV studies found that 
the prevalence of head and neck symptoms in this population is about 80% and oral 
manifestations are the most frequent (as opposed to symptoms in the neck, sinuses, 
and ears) (Sanjar, Queiroz, & Miziara, 2011).  While 80% of patients may not carry a 
formal diagnosis of dysphagia, several oral complications such as candidiasis or oral 
herpes zoster can cause dysphagia or odynophagia.  
Most often, these infections and malignancies are treated through medication 
(antivirals, antifungals, antibiotics, and antituberculosis), chemotherapy, radiation, or 
surgery. There are also non-infectious causes of dysphagia in the HIV/AIDS 
population, such as pill impaction or ulcerations due to medication that does not 
dissolve and remains at the level of the esophagus. This finding appears common in 
patients who use the numerous HAART medications or even medications needed to 
resolve oral lesions (Bobba, El-Dika, & Arsura, 2007). 
Changes or damage in the central nervous system (CNS) stemming from 
cerebrovascular accident (CVA) or stroke can cause neurogenic dysphagia, which is 
characterized by motor and sensory impairments of the oral or pharyngeal phases of 
swallowing (Buchholz, 1994). Generally, CVAs can cause dysphagia in about 51-
55% of patients (Martino, et al., 2005). The prevalence of stroke in HIV patients 
ranges between 6-34% according to various studies (Rabinstein, 2003; Ortiz, et al, 
2007). Stroke in this population does not only affect older individuals, as it has been 
found that young adults with advanced HIV appear to be at increased risk for either 
cerebral infarction or intercranial hemorrhage (Modi, Modi, & Mochan, 2006). This 
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could indicate that dysphagia in this population may occur regardless of age, 
especially when the etiology is from stroke. Individuals with CNS involvement ar 
also at risk for increased fatigue, which in turn may affect swallowing fu ction and 
nutritional intake (Logemann, 1998). In addition, neuromuscular impairments seen at 
times in individuals with HIV, such as Bell’s palsy and facial nerve paralysis, may 
make chewing and swallowing difficult (Bladon & Ross, 2007), causing a diagnosis 
of dysphagia.  
 Previous studies of patients with HIV/AIDS have not been able to determine 
the incidence/prevalence specifically associated with dysphagia. Studies have 
discussed the presence of oral lesions because they greatly affect quality of life and 
can be indicators of the progression of immunosuppression (Barr, 1992; Sanjar, 
Queiroz, & Miziara, 2011). Some studies have reported dysphagia or odynophagia as 
a complaint of patients with HIV (Chelbowski et. al, 1989; Anteyi, et al., 2003; 
Bladon & Ross, 2007; Tirwomwe et al., 2007). One study noted dysphagia in 21% of 
a cohort of 71 adult males (Chelbowski et. al, 1989). Another study reported 
odynophagia (usually due to esophageal involvement or oral lesions) in 22% of cases 
(Anteyi, et al., 2003). Bladon and Ross (2007) found other complaints of swallowing 
difficulty in 79.2% of their sample of 120 patients with HIV. These included 
symptoms such as heartburn, dry mouth, nasal regurgitation, and food falling out of 
the mouth. Percentages for classic symptoms of dysphagia in their study were as 
follows: difficulty chewing (17.5%, n=21), difficulty swallowing (20.8%, n=25), pain 
on swallowing (24.2%, n=29), coughing while eating or drinking (15.5%, n=21), and 
choking while eating or drinking (8.3%, n=10) (Bladon & Ross, 2007). These data 
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were gathered through patient report and were not confirmed by a speech language 
pathologist or instrumental examination. Researchers have focused more on the 
infections that cause dysphagia rather than the swallowing disorder itself.  Thus, there 
is little information on exact incidence of HIV and dysphagia in a large sample. 
 Because difficulty in swallowing limits caloric intake, dysphagia is a 
symptom or contributing factor to severe weight loss in individuals with HIV/AIDS 
(Jacobson, et. al, 2003). Acute weight loss in this population was associated with oral 
symptom complexes (mouth sores, thrush) and trouble swallowing (Jacobson et al., 
2003). In this study, the researchers conducted semiannual telephone interviews with 
415 patients about weight loss and physical symptoms of HIV (e.g. genital tract, 
upper and lower respiratory tract, and gastrointestinal symptoms). Almost 6% of 
participants reported trouble swallowing as a complaint and oral system complex 
complaints were reported by 6.7%. The authors found that acute weight loss was 
associated with oral symptom complexes (mouth sores, thrush) and trouble 
swallowing (Jacobson et al., 2003).  They concluded that 15% of the increased risk of 
acute weight loss was explained by the occurrence of oral symptom complex and 
trouble swallowing, among other symptoms in HAART recipients.  
In addition to the connection between dysphagia and weight loss, researchers 
have begun to investigate whether or not dysphagia is under-diagnosed in patients 
with HIV.  Patients may only be treated for the infectious etiology and not examined 
further in regards to the effects that the dysphagia may cause.  In a study by 
Halvorsen and colleagues in 2003, swallowing problems were present in HIV patients 
whose videofloroscopic exam did not display esophagitis, which in this study 
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encompassed infections such as Candida albicans, herpes simplex or CMV. They 
observed swallowing dysfunction in all of the phases of the swallow and documented 
both frank aspiration and silent aspiration. These findings suggest that even patients
who do not present with indicators of esophagitis upon physical examination but do 
complain about difficulty swallowing should have further instrumental testing; the 
speech-language pathologist should be involved in their patient care. It may also be
surmised from this study that many patients may have dysphagia and silently 
aspiration, but they are not being referred to the speech pathologist for further 
evaluation. Halvorsen and colleagues  also found that several patients who had recent 
CT or MRI examinations of the brain had various CNS infections such as CNS 
toxoplasmosis, multiple infarcts, or CNS lymphoma. They postulated that these 
etiologies might be the underlying cause of the subjects’ dysphagia. This finding and 
Bladon and Ross’ (2007) finding that some individuals with a CD4 count greater than 
500 also complained of swallowing difficulties suggests that dysphagia can occur 
early in the course of HIV infection. This may support early SLP involvement with 
individuals with HIV/AIDS to further screen or evaluate swallowing to avoid silent 
aspiration.   
Bladon and Ross (2007) reported complaints about swallowing difficulties in 
individuals with HIV.  Their subjects often experienced swallowing difficulties in 
multiple phases of the swallow. They also explored the relationship between reported 
swallowing difficulties and CD4 count ranges. Individuals with CD4 counts of 500 
and under seemed to report the most complaints. This observation was not significant 
for every swallowing complaint and a clear association between CD4 and swallowing 
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difficulties could not be made. The same study found that some individuals with a 
CD4 count greater than 500 also complained of dysphagia symptoms, which suggests 
that swallowing difficulties can occur early in the course of HIV infection, especially 
in the period when individuals are first prone to infections.  
Speech-language pathologists’ role in the care of HIV/AIDS patients with dysphagia 
Speech language pathologists use both objective testing, such as the modified 
barium swallow study, or more subjective clinical observations at bedside to evaluat  
swallowing and document the existence and severity of a patient’s dysphagia. These 
clinical tests assess oral motor functioning and attempt to predict the patient’s ability 
to safely swallow various food consistencies. SLPs also make recommendations for 
food consistency in the diet and can assign therapeutic or rehabilitative exercis s to 
help improve swallowing function and prevent choking or aspiration. In the typical 
case of an individual with HIV/AIDS, aSLP is only included upon referral from a 
physician or other healthcare professional and is usually not involved in treatment of 
swallowing until the later stages of the disease, even though mild dysphagia can occur 
early in the infection. Therefore, it has been suggested that swallowing function 
should be evaluated earlier in the course of the infection to prevent or remediate 
further complications (Bladon & Ross, 2007; (Halvorsen, Moelleken, & Kearney, 
2003)).  
Speech language pathologists can recommend dietary consistencies for 
individuals with dysphagia. SLPs may follow the National Dysphagia Diet (NDD) 
guidelines when recommending diet consistencies for individuals with dysphagia. 
These diets include consistencies such as pureed, mechanically soft, and advanced 
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soft food consistency (National Dysphagia Diet Task Force, 2002). Bahl and Hickson 
(1995) described some of the dietary considerations of individuals with HIV and 
dysphagia and suggested that modifications in food consistency and texture to a more 
liquid or semi-liquid consistency were beneficial. These consistencies could be 
especially beneficial for HIV/AIDS patients who experience dysphagia or 
odynophagia as a result of oral/esophageal candidiasis or thrush, which are some of 
the most commonly reported complaints. They also suggested certain feeding 
strategies (e.g., changing food temperatures, body positioning during eati, etc.) to 
alleviate pain, reduce swallowing difficulty, and promote better nutrition.  
Cognitive changes and dysphagia in individuals with HIV/AIDS   
Individuals with disorders of a cerebral etiology have the potential to develop 
dysphagia if the dysfunction occurs in cortical areas that control motor activity of the 
oral-pharyngeal-esophageal structures. Also, people with cognitive disorders such as 
dementia, memory loss, or cognitive decline may also experience difficulty chewing 
and swallowing (National Institute on Deafness and Other Communication Disorders, 
National Institutes of Health, 2010). It is important to explore how swallowing 
difficulty affects this population because when one has dysphagia, they must adhere
to strict dietary guidelines and therapeutic recommendations in order to compensate 
for their swallowing deficits. It would also be important to know if and/or how 
cognition or cognitive deficits affects a person’s ability to adhere to treatment 
strategies for dysphagia. 
Before the development of HAART medication, one study noted that 30 % of 
AIDS patients developed dementia with some associated motor impairment (Bell, 
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2004). After the widespread use of HAART, the number of infections that attacked 
other systems decreased, but pathologies in the central nervous system (CNS), 
particularly cognitive impairment, seemed to persist. This may be due to the fac  that 
the medications do not effectively cross the blood brain barrier in sufficient quantities 
to block and suppress HIV replication in the brain, therefore allowing the brain to be 
a viral reservoir for the HIV virus (Bell, 2004). Other studies have found a frequency 
of cognitive impairments as high as 15% in patients without HAART medication 
(McArthur et al., 1993) and as low as 1%, after the widespread usage of HAART 
medications (McArthur, 2004).  
HIV/AIDS can cause several neurological disorders, which can result in 
cognitive difficulties or dementia. These can include be focal brain diseases such as 
cerebral toxoplasmosis, primary central nervous system (CNS) lymphoma, 
progressive multifocal leukoencephalopathy and stroke (Spudich, 2008). Cognitive 
impairment can also be caused by diffuse brain pathologies such as cytomegalovirus 
encephalitis, neurosyphilis, and CNS cryptococcal infection (Spudich, 2008). HIV-
Dementia or AIDS dementia complex itself, which will be discussed below, is a 
diffuse brain disease caused by the HIV and no other opportunistic disease in the 
central nervous system (Spudich, 2008). 
Specific neurological conditions affecting cognition have been described in the 
literature and they are known as HIV-associated neurocognitive disorders (HAND) 
(Antinori, Arendt, Becker, et al., 2007). HIV-1 associated minor cognitive-motor 
disorder (MCMD) and HIV-associated dementia (HAD), HIV-Dementia (HIV-D) or 
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AIDS dementia complex are just some of the classifications under the umbrella of 
HAND.  
To further clarify the disorders of HAND, three classifications are described 
in Navia et al., (1986), including the most severe, global cognitive impairment, 
moderate dementia, and the least severe, mild dementia.   
To diagnose HIV-associated dementia (HAD), there must be an acquired 
abnormality in at least two of six neuropsychological domains: attention, informati n 
processing speed, abstraction, visuospatial skills, memory, and language. There must 
also be dysfunction in daily activities. Individuals with clouding of consciousness (i. . 
delirium) and evidence of another etiology for the impairments are excluded from this 
diagnosis (Hinkin et al., 2001). 
Some of the early signs and symptoms of AIDS dementia complex are 
forgetfulness, loss of concentration, increased time to complete mental tasks, los  of 
balance, deterioration of handwriting, apathy, organic psychosis, and behavioral 
regression. Late manifestations include moderate-severe dementia, motor weakness, 
ataxia, tremor, and myoclonus (involuntary twitching of muscles) in addition to the 
worsening of the earlier symptoms (Navia et al., 1986). To define minor cognitive-
motor disorder (MCMD), at least two of these six symptoms must be present: 
impaired memory, slowed movement, impaired attention or concentration, mental 
slowing, incoordination, and/or personality change/irritability/lability (Hinkin et al., 
2001).  There must also be documentable minor functional impairment of activities of 
daily living (ADLs), and no other known etiology for the symptoms. Also, motor 
impairment may or may not be present (Hinkin et al., 2001).  
                                                                             
15 
There recently has been a shift in the description and classification of HAND. In 
2007, researchers reclassified these disorders into three groups rather than two 
(MCMD and HAD). The current classifications are asymptomatic neurocognitive 
impairment (ANI), mild neurocognitive disorder (MCD), and HIV- associated 
dementia (HAD) (Antinori, Arendt, Becker, et al., 2007). These new terms are mostly 
used in research while the older classification is still used clinically. 
Risk factors for developing a HIV-associated neurocognitive disorder are older 
age, advanced HIV, increased viral load, comorbidities such as anemia, 
cytomegalovirus, herpes virus, or a history of intravenous drug abuse (IVDA) or 
delirium, and female gender (McArthur, Brew, & Nath, 2005; Gallego, Barreiro, & 
Lopez-Ibor, 2011). Women may be more vulnerable to cognitive impairments such as 
HIV-D, based on performance on procedural learning tasks (Martin, et. al, 2011). 
From these results, it may be speculated that women could be at risk of poor 
nutritional outcomes if they suffer from both dysphagia and cognitive impairments.  
 Although the terms dementia and HAND are often used to describe the 
etiology of cognitive impairment in this population, there can be several causes of 
cognitive impairment. For example, substance abuse, neurosyphillis, brain injury, 
brain tumors, central nervous system infections and adverse effects to medication can 
all cause cognitive changes (American Academy of Neurology, 1991). Chronic HIV 
exposure, associated with significant neuronal loss, may induce HIV-associated 
dementia. This specific progressive cognitive/motor syndrome is observed in 
approximately 20% of patients with AIDS (Scaravilli, Bazille, & Gray, 2007). An 
abundance of microphages appears to be a greater factor in HIV dementia than the 
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presence or extent of brain infection. Late stage HIV infection and an increase in 
trafficking of precursors of macrophages (monocytes) to the brain, may be associated 
with development of HIV neurological disease (Gartner, 2000). HIV-D rarely 
develops before profound immunosuppression (McArthur, Brew, & Nath, 2005), 
therefore, HIV-D or HAD may be the initial AIDS-defining condition in up to 10% of 
patients (Navia, 1990). Today, since the advent of HAART, these cognitive 
conditions are not only seen as an initial AIDS-defining condition and no longer are 
diseases that signal imminent death (Dougherty et al., 2002).  
If an individual is apt to develop dysphagia due to infections of the oral 
cavity, they may also be apt to developing HIV-associated cognitive disorder in 
addition to the oral symptoms. Cognitive impairment might affect dysphagia care 
because patients may experience the symptoms that are described above that havea 
direct impact on therapeutic swallowing recommendations and techniques. Impaired 
attention and concentration will interfere with learning and implementing swallowing 
strategies. Impaired memory will not only impact the learning and understanding of 
the changes needed in the diet, they hinder the person from remembering that the 
changes were even implemented at all. This could put them at risk for aspiration or 
choking. Individuals with dementia (including HIV Dementia) may not fully 
understand their swallowing difficulty and the cognitive deterioration contributes to 
eventual disability in independent eating (Stipinovich, 2010). 
A study found that a person with dysphagia is at 31% greater risk for 
aspiration when they are not oriented to person, place, or time (Leder, Suiter, & 
Warner, 2009). This same study showed that when the patient is unable to follow 
                                                                             
17 
single-step verbal commands, they are more at risk for aspiration and being demed 
unsafe for oral intake. Compensatory swallowing strategies (e.g., Mendelsohn 
maneuver, chin tuck/head turn) often involve one-to-two step commands that are at 
times abstract or complex. A person who is unable to follow or recall these types of 
sequential commands is less likely to use them and is at greater risk for aspirating. 
Another study found that individuals with severe cognitive impairment and dysphagia 
were more successful with oral intake, with significant assistance, whilethos  with 
mild-moderate cognitive impairments fared worse with oral intake (Steele et al., 
1997). This is likely due to the fact that they had less assistance. This study focsed 
on the elderly population, none of which had an HIV-related cognitive impairment. 
No previous studies were found exploring strictly HIV/AIDS-related cognitive 
disorders and dysphagia.  
Dysphagia and odynophagia in the HIV/AIDS population would seem to be a 
common occurrence based on the frequency of oral infections; however, there does 
not seem to be a sufficient evidence of the prevalence of dysphagia/odynophagia and 
HIV/AIDS in the literature. Also, there is not much information on how many 
individuals with dysphagia in this population are also affected by cognitive 
impairment, which will impact their care and swallowing safety.  
Purpose and Rationale 
 After a review of the current literature, there appears to be a need to ascertain 
the prevalence of swallowing difficulties in individuals with HIV/AIDS. There is also 
no literature that combines both dysphagia and cognitive impairments in a way that 
documents the frequency of co-occurrence of these disorders in the HIV/AIDS 
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population. The current research is not robust regarding relationships between 
swallowing difficulties and several variables (e.g. age, CD4 count). Also, more data 
might be useful in describing dysphagia in this population, in addition to current 
descriptions of complaints in Halvorsen (2003), Bladon and Ross (2007), and 
Jacobson et al. (2003).  
This is a descriptive research study, which explored the prevalence of co-
morbid HIV/AIDS and dysphagia and co-morbidity of these two conditions and 
various cognitive impairments. This study, we will also explore the associations (if 
any) between these disorders and other factors in HIV such as CD4+ count, age, and 
gender. This study also examines the swallowing outcomes (dietary 
recommendations) of these groups and the frequency of occurrence of swallowing 
deficits at various stages of infection (classified by CD4 cell count range). 
Research Questions 
The following questions will be explored: 
 
1  What is the prevalence of dysphagia in a large sample of patients with 
HIV/AIDS? 
1.1 Do referred versus non-referred groups with dysphagia differ in 
demographics and diagnostic profiles?  
2  What is the prevalence of dysphagia and cognitive impairments in this 
sample? 
3  Is there any association between age and CD4 count and the presence of 
dysphagia? 
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4  For those patients with dysphagia, is there any relationship between age, CD4 
count and the recommended diet consistency?  
5  Do patients with both dysphagia and a cognitive impairment differ from 
patients without cognitive deficits in the severity of dysphagia (evidenced by 
oral motor abilities and penetration/aspiration status) or in recommended diet 
consistencies at discharge? If so, in what ways?  
 





 Three hundred (300) randomly selected medical charts at Washington 
Hospital Center in Washington, D.C. were examined for this study. Information from 
each medical chart was obtained from the online data storage database Axxyzi (a 
hospital-wide database that houses the medical records of all patients seen at th  
Washington Hospital Center complex) and/or through review of physical medicine 
charts accessed directly through the Health Information Management Deparm nt. 
The first 300 medical entries found in a search query of patients with a diagnosis of 
HIV/AIDS were included in this study. The patients included were at least 21 years of 
age to avoid involvement of pediatric cases. All patients included had acquired HIV, 
rather than having HIV congenitally. These patients were admitted to the acute care 
or inpatient units at Washington Hospital Center between the months of April 2008 to 
April 2011. Washington Hospital Center is the largest private hospital serving the 
Washington, D.C. metropolitan area.  Permission to gain access to these charts was 
granted through the Institutional Review Board (IRB) at the Medstar Research 
Institute (2011-076) and the University of Maryland (11-0437).  
Charts from 159 males and 141 females were included in this review, with 
ages ranging from 23-81 (mean= 45.92, median= 47). These patients were 
predominately from the Washington, D.C. metropolitan area (including parts of 
Maryland and Virginia).  
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Documentation of HIV Positivity and Immunosuppression Using CD4 Counts 
Individuals were included in the study based upon a diagnosis of HIV or AIDS 
and staged by CD4 cell count laboratory results obtained from a chart review.  
For the purposes of comparison in this study, the patients’ actual CD4 counts 
were used but the CDC categories were also noted. However, due to limitations in full 
medical history, the data collected may not have been the patient’s lowest CD4 count, 
but the most recent CD4 for that particular hospital admittance. This was collected to 
help classify the subjects by stage/severity of their infection in preparation for 
comparison.  
Documentation of Age 
 As stated in the participants section, the ag s collected in this sample ranged 
from 23-81 with a mean of 45.92 and a median of 47. The subjects’ ages were 
recorded from the medical chart. Ages were also grouped using a median split. Using 
this variable code, the age groupings were ages 23-47 and 48-81.  
Documentation of Swallowing Deficits 
Patients were identified as having dysphagia through a series of inclusionary 
factors obtained from chart review which included: medical history, physician and 
nursing notations, objective instrumental test results, bedside clinical swallowing 
evaluations, and diet recommendations upon discharge.  If referred for assessment of 
swallowing, swallowing impairment was diagnosed by a certified speech-language 
pathologist with at least two years of clinical experience post-graduation. Swallowing 
impairment was documented based on a clinical bedside swallowing evaluation 
and/or instrumental evaluation of swallowing (i.e., modified barium swallow study, 
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fiberoptic endoscopic evaluation of swallowing). The presence of penetration or 
aspiration was documented after reviewing objective videofluoroscopic swallow 
studies using the Penetration-Aspiration Scale (Rosenbeck et al., 1996).  This scale is 
used by speech pathologists during instrumental evaluations of swallowing (e.g., 
modified barium swallow studies). It is a scale that ranks the presence of penetration 
or aspiration ranging from a score 1-8, with 1 indicating that no material from the 
swallowed bolus enters the airway and 8 indicating that material from the bolus enter  
the airway and no attempt is made to eject the bolus. The 8 level scale has a 
numerical rating  that differentiates between  penetration of a bolus ( material rests 
above the vocal folds)  and aspiration of a bolus (material passes through the glottis 
and enters the airway) , and also includes the degree of effort needed to clear the 
airway in the rating scale.    
In the case of individuals with dysphagia or odynophagia caused by infection 
or inflammation (e.g., candidiasis, herpes simplex/zoster) in this sample, dysphagia 
was based on physician report of patient complaint found in the charts. Patients were 
grouped together based upon the presence of dysphagia or odynophagia with an 
infectious/inflammatory etiology and if they were only seen by their primary 
physician.  If they were referred to the speech pathologist for documentation of 
dysphagia with other, most likely neurological, etiologies, then they were also 
grouped together in a separate group..  
The presence of swallowing disorders was determined from therapy notes and 
reports in the medical chart which described signs and symptoms of dysphagia 
associated with each phase of the swallow. Noting all signs and symptoms of 
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dysphagia was done to further document and describe the type of dysphagia the 
patient had and to provide physiological information needed for dietary 
recommendations.  
 The most common phase deficits and symptoms in swallowing are defined 
relative to swallow physiology and /or bolus transport (Groher & Crary, 2010; 
Washington Hospital Center Hearing and Speech Center swallowing assessment 
Form 2349). These deficits are based on clinical observations and findings from 
modified barium swallow studies and other instrumental testing (e.g. fiberoptic 
endoscopic evaluation of swallowing). 
 Oral/Oral preparatory phase- decreased saliva production, 
(xerostomia), decreased taste, decreased tongue or jaw range of 
motion, difficulty chewing, drooling, decreased labial seal, 
holding, pocketing, piecemeal deglutition, passive flow to 
valleculae or pyriform sinuses, aspiration prior to the swallow 
 Pharyngeal phase- delayed initiation of the swallow, decreased 
hyoid movement, pooling in valleculae or pyriform sinuses, 
decreased epiglottal movement, supraglottic penetration, aspiration 
(during/after a swallow), immediate throat clear or cough after a 
swallow, delayed or absent throat clear or swallow (as evidenced 
on videoflouroscopic examination) 
 Esophageal phase- sophageal reflux, delayed opening of UES, 
delayed esophageal transport (delayed esophageal peristalsis)   
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The oral preparatory and oral phase deficits were grouped together, due to the 
fact that the stages closely overlap and are noted together in the speech language 
pathologist’s evaluation of swallowing found in the charts.  
Documentation of Dietary Consistency Recommendations 
Levels of dietary outcomes prescribed at time of discharge were rated bas  on the 
National Dysphagia Diet guidelines (American Dietetic Association) (National 
Dysphagia Diet Task Force, 2002). Washington Hospital Center has added 3 ratings 
(NPO, Level 0, and Regular) that are not on the National Dysphagia Diet (NDD) but 
were used in their discharge recommendations. These levels were used in the analysis 
of dietary recommendations: 
• NPO (none by mouth; includes PEG or NG tube) 
• Level 0: Full Liquid (Liquids only; soups, juice, water, carbonated beverages) 
• NDD Level 1: Dysphagia-Pureed (homogenous, very cohesive, pudding-like, 
requiring very little chewing ability).  
• NDD Level 2: Dysphagia-Mechanical Altered (cohesive, moist, semisolid 
foods, requiring some chewing).  
• NDD Level 3: Dysphagia-Advanced (soft foods that require more chewing 
ability). 
• Regular (all food textures allowed). 
Documentation of Cognitive Deficits 
 
Patients with cognitive deficits were identified by a chart diagnosis of altered 
mental status, HIV- Dementia (HIV-D), AIDS dementia complex, HIV Associated 
Dementia (HAD), or dementia.  Patients were also identified for further eview if they 
                                                                             
25 
presented with an infection or disease (e.g., neurosyphilis) that could cause cognitive 
impairment and were included if there was a documented cognitive impairment found 
upon further review of the medical records. These patients had their diagnosis 
confirmed by a Mini Mental State Examination (Folstein, Folstein & McHugh, 1975) 
or by neurologist and/or psychiatrist notes or report of a previous diagnosis of 
cognitive impairment found in the medical record.  
Statistical Methods 
The research questions were addressed using frequency counts, descriptive 
statistics and inferential statistics. IBM SPSS (Version 19) statistical software was 
used to complete all statistical analysis in this study.  
Frequency counts were used to document the frequency of dysphagia and 
dysphagia with cognitive impairment. It was also used to document the frequency of 
CD4 cell count ranges and other categorical data. Measures of central tendency (e.g., 
mean, median, mode) were used to describe characteristics of the continuous 
variables of age and actual CD4 count. 
For continuous variables collected in the study, an independent t-test and the 
nonparametric Mann-Whitney U test were conducted. This statistic helped to 
determine if there is a relationship between the presence of dysphagia and age  
CD4 count.  
For analysis using categorical data, a chi square (X 2) was employed. These 
measures helped determine if there are differences between the dysphagia groups in 
regards to CD4 count range, age group, and diet consistency recommendation. While 
categories were expanded to document and describe symptom frequency, severity of 
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immunosuppression, and diet consistency recommendations, as explained in the 
previous sections, to meet the requirements of a chi square analysis, the categories 
were simplified. CD4 counts ranges were simplified to normal CD4 (500 cells/µl3 and 
above) and abnormal CD4 (499 cells/µl3 and below). Age was categorized as 23-47 
and 48-81 using a median split. Diet consistency groupings were simplified to regular 
consistency and altered consistency.  
Subject Groups  
 Charts were examined and categorized into three overall groups and with 
subgroups: 
• Group 1: HIV/AIDS with Dysphagia and no cognitive impairment- This group 
included subjects with confirmed dysphagia or complaints of dysphagia 
and/or odynophagia from oral lesions evidenced in physician notes.  
o Group 1.1 Referred Dysphagia- This group included only individuals 
seen by the speech language pathologist.  
o Group 1.2 Fungal/Infectious Dysphagia – These patients reported 
complaints of dysphagia and/or odynophagia but were not referred to 
the SLP for swallowing evaluation. 
• Group 2: Dysphagia and Cognitive Impairments group- This group of patients 
presented with dysphagia and/or odynophagia and a reported or confirmed 
cognitive impairment.  
• Group 3: No Dysphagia group – This group included the remainder of the 
subjects who did not have reported dysphagia or odynophagia. 
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o Cognitive Impairment and No Dysphagia group- Subjects who had no 
documented dysphagia and odynophagia, but had a documented 
cognitive impairment were placed into this subgroup to document the 
frequency of cognitive impairment in the full sample (when combined 
with the frequency count in group 2). 
 
What is the prevalence of 
 
After reviewing 300 medical charts at the Washingto Hospital Center, 
dysphagia or odynophagia was 
inflammatory, structural, or neurological etiology (Figure 1). 
FIGURE 1 Prevalence of dysphagia in adults with HIV/AIDS 
What is the prevalence of dysphagia and cognitive impairments in this sample?
Figure 2 provides a profile of subgroupings. 
dysphagia and/or odynophagia and no cognitive deficits), there were 48 patients 
(16%), with 9 being referred to an SLP (Group 1.1) and 39 who were not referred 
(Group 1.2). Group 2 (5.7%, N=17) included patients with dysphagia and/or 
odynophagia and a co-morbid reported or documented cognitive deficit. The 
remainder of the sample in Group 3 included individuals without dysphagia (n=235, 
78.3%). This subset was also divided into indiv
cognitive impairment. Twenty subjects in Group 3 (6%) had a cognitive impairment 
(including diagnoses of altered mental status to dementia) and no documented 
dysphagia. When combined with the individuals in Group 2 who al
Results 
dysphagia in a large sample of patients with HIV/AIDS?
found in 65 charts (21.7%) due to an infectious, 
 
 
In Group 1, (individuals with 
iduals with and without a reported 
so had a 
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documented cognitive impairment, there was a total frequency of cognitive 
impairment (regardless of dysphagia status) of 12.3%.  
FIGURE 2 Prevalence of Disorders by Group  
 
Total prevalence of cognitive impairment in this sample was 12.3% (N=37). 
 
Gender  
The distribution of males and females in this sample was relatively equal, with 
53% male subjects and 47% females. In Groups 1 and 3, the male/female ratio was 
almost equal. In Group 2, males were more frequent.  
Is there any association between age and CD4 count and the presence of dysphagia? 
The charts reviewed for this study included adults ages 23 to 81 with 
HIV/AIDS, Age was normally distributed across the sample.  The average age of
individuals in the sample was 45 years (Table 1). Dysphagia coupled with cognitive 
deficits (Group 2) affects more older patients (m=49.53) (Table 1). However, this 
Group 2  had an age range from 24-75 years (Table 1). This observation suggests that 
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cognitive impairment could be due to a combination of normal age effects being 
magnified by the susceptibility to opportunistic diseases and infections that comes 
with HIV/AIDS infection.  A t-test for independent samples was used to compare age 
across groups. The mean age of the combined dysphagia groups (Groups 1 and 2) was 
m = 44.17, sd = 10.153. The mean age of the group without dysphagia (Group 3) was 
m = 46.40, sd = 11.227. This difference was not statistically significant (p =1.449) at 
the .05 level (t = -1.449, df =298).  
       
The CD4 counts of the individual patients were not evenly distributed across 
the sample and were negatively skewed. The group with the lowest average CD4 
count was Group 1.2 (m=50.24), the individuals with oral lesions of an infectious 
etiology (Table 1).  
Of the three CD4 categories as defined by the CDC, the charts reviewed here 
fell mostly in category 3 (<200) across all groups. The majority of the pati nts 
included in this study had advanced HIV infection and/or AIDS as evidenced by a 
median CD4 count of 104 (Table 1) and the fact that 189 out of the 284 reported CD4 
counts were in Category 3. Several of the patients in groups 1, 2 and 3 had a record of 
an AIDS-defining illness such as progressive multifocal leukoencephalopathy, 
disseminated Mycobacterium avium complex, and cytomegalovirus disease. A t-test 
showed that the mean of the combined dysphagia group was m = 73.31, sd = 111.233 
and that the mean from the group without dysphagia (Group 3) was m = 232.25, sd = 
286.137. Because the data was not normally distributed, a nonparametric Mann-
Whitney U test was used to examine the data. The difference between the two m ans 
was significant (p = .000) at the .05 level. 
                                                                             
31 
For those patients with dysphagia, is there any association between age, CD4 count 
and the recommended diet consistency?  
One of the research questions of this study asked if age, CD4 count range or 
diet consistency recommendation could be associated with dysphagia alone or 
dysphagia with cognitive impairments. A chi square (X 2) was used and the variables 
were simplified. The dysphagia groups (Group 1 and 2) were compared using age as 
the variable. Age was split into two groups using a median split, creating ranges from 
23-47 and 48-81. More individuals in the dysphagia only group (Group 1) were 23-47 
years old, while there were more individuals in the dysphagia/cognitive impairents 
group (Group 2) in the 48-81 age range. The relationship between dysphagia group 
and age was significant (p = .02) at the .05 level (x2 = 5.008).  
CD4 counts, simplified to normal CD4 count (500 cells/µl3 and above) and 
abnormal CD4 count (499 cells/µl3 and below) were also examined. All individuals in 
Group 2 and all but one individual in Group 1 had an abnormal CD4 count. 
Nevertheless, the relationship between the groups and CD4 count was not statistically 
significant (p = .56) at the .05 level (x2 = 339).  
 Regular consistency (normal) diets were most frequently recommended upon 
discharge (88%, n=264) (Table 1). Only in Group 2 did more restrictive diet 
consistencies (58%, n=10) occur more frequently than the regular diet consistency 
(29%, n=5), which could be due to the compounding factors of the severity of the 
cognitive impairment, motivation to maintain nutrition, and the ability of the patient 
to swallow safely and independently. Diet consistency recommendations were 
compared across groups 1 and 2. For this analysis, the diet consistency groupings 
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were simplified to two categories, regular consistency and altered consistency. Group 
2 showed more likelihood to be recommended an altered diet consistency than Group 
1. The relationship is statistically significant (p = .001) at the .05 level (x2 = 11.702).  
TABLE 1 Demographic Data, CD4 Counts and Dietary Consistency 
 Recommendations in Adults with HIV/AIDS. 


















Demographic Data      











Median y 47 47 41 50 47 
Female gender % (n) 47 (141) 22 (2) 53 (21) 29 (5) 48 (113) 
Male gender % (n) 53 (159) 77 (7) 46 (18) 70 (12) 51 (122) 













Median 104 115 33.5 33.5 161.5 
      
Diet Consistencies % 
(n)      
NPO 2.3 (7) 22 (2) 0 (0) 23 (4) 0.4 (1) 
Puree 3.3 (10) 11 (1) 5 (2) 29 (5) 0.8 (2) 
Mechanically Altered 1.3 (4) 22 (2) 0(0) 5 (1) 0 (0) 
Advanced 0.7 (2) 11 (1) 0 (0) 0 (0) 0.4 (1) 
Regular 88 (264) 33 (3) 94 (35) 29 (5) 94 (222) 
Unknown# 4.3 (13) 0 (0) 5(2) 11 (2) 3 (9) 
      
Note: *Some patients' CD4 Counts were unknown/undetectable and therefore not counted. 
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TABLE 2 Summary of Findings for Age, CD4 Count, and Recommended Diet 
Consistency Across Groups 1, 2, & 3 




(Group 1 &2) 
(m=44.17) 
Vs. 
Without Dysphagia  






(Group 1 &2) 
(m=73.31) 
Vs.  
Without Dysphagia  
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Do patients with both dysphagia and a cognitive impairment differ from patients 
without cognitive deficits in the severity of dysphagia (evidenced by oral motor 
abilities and penetration/aspiration status) or in recommended diet consistencies at 
discharge?  
Group 1: Dysphagia (Referred and Infectious Etiologies)  
All individuals with dysphagia and odynophagia and no cognitive impairment were 
included in Group 1. 
Group 1.1:  
For those who were categorized as having dysphagia and were seen by an SLP 
(Group 1.1, Table 2), most complained that they “had not been able to eat or swallow 
liquids” and that “food is getting stuck in the back of the throat”.  
Diets in Group 1.1 varied from the most restricted (NPO) to the least 
(Regular). Three of the patients in Group 1.1 were first assigned a modified diet, but 
with time and before discharge, were recommended for a regular diet. Three patients 
who required a tracheostomy tube for breathing were placed on the restricted diets 
(e.g., NPO and liquid diets). Two out of three patients were advanced to less 
restrictive diets once the tube was removed and they were de-cannulated, or if their 
overall medical status improved.  
Chart reviews of bedside clinical examinations and reports of instrumental 
testing of individuals in Group 1.1 revealed that oral deficits included labial weakness 
and deviation, decreases in oral sensation and function (often asymmetrically), and 
secretion management issues (drooling). Passive bolus flow to the valleculae and 
pyriform sinuses and piecemeal deglutition were also observed during swallow 
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studies using various bolus consistencies. Pharyngeal observations from the Modified 
Barium Swallow studies included impaired coordination of pharyngeal structures, 
delayed swallow, residuals and pooling in the pyriform sinuses and valleculae, 
decreased hyoid movement, decreased laryngeal elevation, supraglottic penetration, 
silent aspiration, and decreased/weak abduction of the true vocal folds.  Three 
patients in Group 1.1 had esophageal swallowing issues (e.g. strictures, esophagitis) 
(Table 2).  
According to subjective bedside swallowing evaluations, two patients in 
Group 1.1 showed subtle signs and symptoms of aspiration, such as an intermittent 
cough or throat clearing immediately after swallowing. When using objective 
instrumental measures such as the FEES or MBS, three patients displaye frank 
aspiration with and without protective reflexes. Only two patients in Group 1.1 had 
neurological changes (e.g., CVA) that may have contributed to their dysphagia but 
did not reportedly cause cognitive changes. Another patient with Guillian-Barre 
syndrome, which causes nerve inflammation resulting in muscular fatigue, had 
variable dysphagic symptoms. Dysphagia was a result of prolonged intubation or 
tracheostomy in three patients in Group 1.1. One patient had epiglotitis and swelling 






                                                                             
36 
TABLE 3 Group 1.1 (Referred Dysphagia) Symptoms of Dysphagia by 





(≥ 500 cells/ 





(n= 2)  
Category 3 







Aspiration/penetration 3 0 1 1 1 
Neurological Changes 2 0 1 1 0 
Oral Impairment 3 0 0 2 1 
Pharyngeal Impairment 5 0 2 1 2 
Esophageal Impairment 3 0 0 2 1 
 
      
Group 1.2:  
Many of the subjects in this group (Group 1.2) complained of painful 
swallowing (odynophagia) as well as difficulty swallowing, but were not referr d to 
an SLP. Thirty-five patients with infectious etiologies and dysphagia/odynophagia 
(Group 1.2) were placed on a regular consistency diet, despite pain on swallowing. 
One patient was recommended to be placed on a diet of thickened liquids in addition 
to regular consistency meals. Because none of the patients in Group 1.2 were seen by 
an SLP, it cannot be confirmed that a specific swallowing phase was affected.  For 
example, if a patient had esophagitis, it may be assumed that the esophageal phase of
the swallow would be impaired and that they would have discomfort during ingestion. 
If the person had oral thrush, then it may also be assumed that the oral phase of the 
swallow would be affected. Sixteen subjects in Group 1.2 had esophageal lesions or 
diseases and 29 had oral lesions or complaints. Neither penetration nor aspiration was 
reported in individuals in Group 1.2. The causes of dysphagia/odynophagia in Group 
1.2 can be found in Table 3, which displays the etiologies of fungal diseases.  
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TABLE 4 Infectious Etiologies of Dysphagia for Group 1.2 (Fungal/ 










(n= 2)  
Category 3 





(n= 2)  
Neurological Changes 0 0 5 0  
Oral Thrush 0 1 16 1  
Candida Esophagitis 0 1 8 1  
Oral Candidiasis 0 0 8 0  
CMV Esophagitis 0 0 1 0  
Oral/Gum/Palatal Ulcer 0 0 3 0  
Esophageal Inflammation 0 0 1 0  
Herpes Simplex Esophagitis 0 0 1 0  
Esophagitis 0 0 1 0  




Group 2: Dysphagia and Cognitive Impairment 
 
With only 17 patients, this group was the smallest group. This group had the most 
detailed reports, as they were most often referred to a speech-language pathologist.  
Because of cognitive involvement, the patients in this group often could not or did not 
make first-hand complaints about their swallowing difficulties. Swallowing 
difficulties often caused poor oral intake, decreased weight and malnutrition. Four of 
these patients progressed from a very restricted diet to a less-restrictive diet, but only 
five were recommended to be placed on a regular diet upon discharge.  
 
This group, as a whole, experienced swallowing impairment at all phases. 
Eight out of 17 patients (47%) with documented swallowing impairments experienced 
deficits at multiple swallowing phases. One subject had deficits at all three p as s, 
while seven had two phases affected (Table 4).  Four patients had impaired oral mot 
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abilities, which could be associated with the frequent occurrence of cerebral infa ct. 
Five patients in this group had facial paresis characterized by decreased labial seal, 
decreased bolus containment and poor management of secretions (drooling). Other 
oral phase deficits included delayed swallow, pooling in the mouth, impaired bolus 
formation, delayed bolus manipulation, delayed oral transfer and clearing, passive 
flow to valleculae and pyriform, and piecemeal swallow across various consistencies. 
In the pharyngeal phase, impairments observed included overall incoordination of the 
swallow, decreased laryngeal elevation, pharyngeal residuals, and aspiration and 
penetration. As far as esophageal involvement, two patients had infections in the 
mucosal membranes covering the tissue (e.g., esophageal candidiasis) causing 
odynophagia. Nine of the patients had oral or esophageal infections that contributed 
to their dysphagia/odynophagia, including oral and esophageal candidiasis, oral 
thrush, and cytomegalovirus (CMV) esophagitis.   
 Patients in this group displayed varying frequencies of penetration and 
aspiration on a specific rating scale, the Penetration-Aspiration Scale (Ros nbeck et 
al., 1996). One individual in this group displayed silent aspiration, evidenced by a 
score of 8 out of 8 (material enters the airway, passes below the vocal folds, and no 
effort is made to eject) on the Penetration-Aspiration Scale (Rosenbeck et al., 1996). 
Scores of 2 out of 8 (material enters the airway, remains above the level of the vocal 
folds, and is ejected from the airway) and 4 out of 8 (material enters the airway, 
contacts the vocal folds, and is ejected from the airway) were also assigned to patients 
based on the observations after modified barium swallow studies. Three patients had 
no visible aspiration, but they had factors that put them at risk for aspiration, such as a 
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CVA, cognitive impairment, or impaired oral mobility. Other signs and symptoms of 
risk of aspiration that were noted were immediate cough/ throat clear after thin liquid 
and puree trials, cough/throat clear delayed after thin liquid trial and ice chips, weak 
cough or throat clear, and watery eyes.  
Aspiration was documented in 7 out of 17 patients in this group. Eight of the 
patients in Group 2 had acute stroke in their medical history. Five patients also had 
accompanying aphasia. The diagnoses of dementia came from neurology or other 
physician notes/observations or a past medical history of HIV related dementia. Many 
of those with mild cognitive problems such as altered mental status also had 
accompanying diagnoses of fever, Progressive multifocal leukoencephalopathy 
(PML) and HIV encephalopathy, among other diagnoses. Neurological events that 
occurred in these patients included seizures, head injury and stroke (CVA) resulting 
in aphasia, right-side neglect, and facial and bodily paresis. Based on observations 
made from the data, it appears that individuals in Group 2 had the highest frequency 
of aspiration (7/17) and were put on a more restrictive diet (10/17).  












(n= 1)  
Category 3 







Aspiration/penetration 7 0 0 6 1 
Neurological Changes 9 0 0 7 2 
Oral Impairment 12* 0 1 9 2 
Pharyngeal Impairment 9* 0 0 9 0 
Esophageal Impairment 3* 0 0 3 0 
* = Patients have multiple phases affected    
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Discussion 
After a review of 300 medical charts, dysphagia was noted in 21% of patients. 
This prevalence rate is consistent with the numbers reported by other studies that 
noted or examined dysphagia directly (Chelbowski, et al., 1989; Bladon and Ross, 
2007; Tirwomwe et al, 2007).  However, the frequency rate of 21% was slightly 
higher than what was reported in some other studies (Jacobson et al., 2003). It 
appears that dysphagia is a common symptom of HIV/AIDS and that it can occur 
relatively frequently.  
In our sample, we found that only 5% of patients were coded for dysphagia and a 
cognitive condition. No other studies could be found that explored the frequency of 
both dysphagia and cognitive impairment together. The cognitive conditions in this 
sample set included altered mental status and mild to severe HIV/AIDS-related 
dementia and could certainly complicate treatment. 
Dysphagia can occur with any CD4 count range from low to high (Bladon and 
Ross, 2007; Barr, 1992; Sanjar, Queiroz, & Miziara, 2011; Vazquez, 2000). Our 
study revealed that dysphagia occurred primarily in the most severe CD4 count class 
(>200 cells/ cubic microliter) (63%, n=189 in CD4 category 3). This may be 
attributed to a number of factors. Because the patients with a high CD4 count are the
most immunocompromised, they are at greatest risk of succumbing to opportunistic 
infections and may develop dysphagia from these diseases and infections. Also, it is 
possible that this finding could be a result of sampling error. Because this study was 
done with severely involved acute care patients who have to be hospitalized because 
they are sick or at their sickest, it is to be expected that their CD4 count would be in 
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the severe range. However patients with very low or very high CD4 counts were 
found in each group.  
We found that there was an association between age and the presence of 
dysphagia in individuals with HIV/AIDS, but there was a relationship between CD4 
count and the presence of dysphagia. Because the mean of the dysphagia group was 
lower, it could imply that individuals with lower CD4 counts are more likely do 
develop dysphagia or an opportunistic disease in which dysphagia is a resulting 
symptom. We found no significant relationships between a diagnosis of dysphagia 
with and without cognitive impairment and CD4 count, but there is a relationship 
between these groupings and age and diet consistency recommendations. This finding 
helps confirm the observation that older individuals with HIV/AIDS are more likely 
to have the co-morbidities of dysphagia and cognitive impairment than younger 
individuals. These findings also help confirm the observation that individuals with 
cognitive impairment and dysphagia are more likely to be put on a restrictive diet 
than individuals with dysphagia only.  
An interesting observation found in Group 1 is that three out of nine patients 
were put on a regular diet when dysphagia was not treated with medicine (as in the 
case of fungal dysphagia) and despite signs and symptoms of dysphagia. This could 
have a negative impact on the client’s health. No follow-up could be found on these 
patients, so we are unsure of their success on these diets. If a person with dysphagia i  
put on a regular consistency diet, they may be more at risk for aspiration due to the 
varied textures and consistencies of the bolus. This observation suggests a need for 
the medical team and the SLP to devise better guidelines about HIV/AIDS care and 
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the speech pathologist’s role in treatment.  It is suggested that follow-up sho ld be 
initiated to see how successful discharged patients are with these diets. 
Aspiration was documented most frequently in Group 2. It is unclear whether 
it occurs more in this group because there is a neurological component that could 
cause a more severe dysphagia, or if it is just documented more frequently because 
individuals with a neurological event (e.g. stroke, TBI) are automatically seen by the 
SLP in this particular hospital. 
Limitations:  
There were obvious limitations to this study. First, this was a retrospective 
analysis of actual medical charts that were used in patient care and not annotaed for 
the purposes of research. Therefore, there was no control over data in charts or in the 
examinations that were reported. Some charts were more detailed than others. In 
some cases, only the discharge report, physician’s notes, and lab results were on fil  
and in other cases, the complete file could be retrieved. Another limitation for the 
dysphagia subject data (Groups 1 and 2) is that not all were seen by the SLP; the diets 
may have been recommended by a doctor or nutritionist who did not consider the 
therapeutic implications of a dietary plan in the way that an SLP would.  Many 
patients with infectious oral lesions who could have been referred to a SLP were not 
referred and were not given formal dysphagia assessments. Also, there was no y of 
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Clinical Implications:  
This study provides more evidence that dysphagia and odynophagia are 
substantial complaints in the HIV/AIDS population and that more steps should be 
taken to educate professionals who work with HIV patients, (including physicians, 
nurses, and SLPs), in the diagnosis and management of swallowing disorders. This 
study also suggests that cognitive impairments can co-occur with dysphagia across 
the age range and that this small subset of the HIV/AIDS population may experience 
significant deficits which require more strict dietary guidelines and professional 
assistance in order to maintain an adequate quality of life. Better management and 
follow-up might lead to less need for acute care or re-hospitalization and could reduce
the risk of aspiration pneumonia.   
Future Research Needs:  
The limitations of the current study are common in retrospective research. 
Prospective study could eliminate these limitations. A prospective study based upon 
this research would allow further exploration into how cognitive impairments affect 
dysphagia management and how the co-treatment of these disorders impacts the 
health of the individual. This study should have documentation of baseline severities 
of both dysphagia and cognitive impairments in order to have better control over 
subject selection and extemporaneous variables. Follow-up is needed with patients 
having HIV/AIDS to see how well they are adhering to recommended diet 
consistencies or prescribed oral motor exercises and compensatory strategies. Future 
research could also explore the need for more objective studies of 
dysphagia/odynophagia in this population. Prior research has shown risk of 
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aspiration, especially in the face of infectious/structural complications of HIV (e.g. 
(Halvorsen, Moelleken, & Kearney, 2003).  In this study many of the patients were 
not seen by the SLP unless they were consulted following a stroke or other 
neurological events. However, evaluation of swallowing when the etiology is an oral 
lesion might be beneficial to the patient who may be silently aspirating because the 
oral infection has reduced their sensitivity in the pharynx. This may indicate a need 
for consistent referrals of these patients to a speech pathologist for further 
investigation of the patient’s swallowing abilities. From more consistent referrals, 
SLPs can begin to develop standard set of measures of the risk of aspiration and 
penetration and on treatment for this population.  
Future research should also focus on clarifying the most successful diets for 
this population and proper follow-up protocols after discharge. In conjunction with 
nutritionists, the SLP could focus on the safest diet consistencies while maintaining 
optimal nutrition, since nutrition is especially vital to wellness in this population. 
Future research may also help guide speech language pathologists and other 
professionals who help treat HIV and dysphagia to better understand the effects of 
diet consistencies on these patients, whether they have mild dysphagia from an oral 
lesion or severe dysphagia from a stroke.  
Additional research should include patients who are not at their sickest point 
and require hospitalization.  Rather, data are needed from outpatients in community 
treatment facilities.  Examining patients who come in for regular check-ups to see if 
they have dysphagia/odynophagia, (and/or cognitive impairment) and documented 
CD4 count may help confirm or deny whether there is a relationship between CD4 
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and dysphagia. A wider population sample, including those in sub-acute care, 
rehabilitation, or those who are only under the care of the primary physician, could 
document how well compensatory measures are used in the treatment of 
dysphagia/odynophagia and cognitive impairment outside of the hospital setting. This 
research should also eliminate some of the limitations of the current study by 
controlling for variables and matching treatment methods to presenting symptoms. 
Dysphagia and odynophagia are dangerous and uncomfortable disorders that 
are present in over 20% of the HIV/AIDS population, causing numerous problems 
including aspiration pneumonia and malnutrition. Dysphagia negatively affects a 
patient’s quality of life and nutrition. If this disorder is treated properly, these patients 
may have a better chance to thrive by eliminating the chances of becoming 
malnourished or developing pneumonia. When coupled with cognitive deficits, which 
affected 5% of this population, a patient’s ability to manage dysphagia or 
odynophagia may be more difficult. While the number of individuals with these 
concurrent diseases are small, this population will require special care and 
collaboration between medical professionals, which will only occur with further 
knowledge, and understanding of how these diseases impact the health and daily life 
of those affected.    
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